How Flex Databases’ Review and Merge Tool Transforms Pharmacovigilance Case Processing

August 25, 2026

How Flex Databases’ Review and Merge Tool Transforms Pharmacovigilance Case Processing

Every pharmacovigilance case tells an evolving story. A case rarely arrives once and stays static – new information keeps surfacing after the initial intake: a patient is hospitalized, a birth date gets corrected, a new reaction is reported, a concomitant medication comes to light. For safety teams processing cases from clinical trials, marketed-drug consumer reports, or regulatory authority feeds, this constant stream of updates is simply part of the job.

The question is: how much time and risk does it take to keep up with it?

Where PV Cases Actually Come From

Case intake is rarely a single channel – it’s a convergence of several:

  • EDC systems from clinical trials – when a patient experiences an adverse event on an investigational product, the investigator reports it, and the case flows into the PV system.
  • Client relation forms for marketed drugs – any consumer can report an adverse event directly through a pharma company’s website.
  • Partners and regulatory authorities – cases can arrive as structured XML imports, for example when a doctor or consumer reports an event to a regulatory authority and the sponsor imports that data, or when an international partner relays safety data back.

Each of these channels can generate not just a new case, but repeated updates to an existing case — sometimes dozens of them for a single ADR or serious case.

The Problem: Every New Version Meant Starting Over

BEFORE
✗  New case version replaces the old one with zero visibility into what actually changed
✗  Prior medical coding, causality assessment & narrative work is lost, not carried forward
✗  A single-field correction still triggers a full case re-review ✗  Serious cases with dozens of follow-up versions multiply manual rework
AFTER
✓  Every incoming update is shown as a clear, field-level diff against the prior version
✓  Reviewers choose to keep, edit, or replace each field – no re-entry from scratch
✓  Minor changes are resolved in seconds; deep review is reserved for what matters
✓  Follow-ups & amendments are classified and logged, even if the source omits the flag

The Fix: See What Changed, Decide What to Keep

The Review and Merge Tool addresses this at the source – by treating an incoming update not as a replacement, but as a delta to be reconciled against existing work.

Change visibility See exactly what changed between case versions – no manual side-by-side comparison.
Field-level control Carry over, modify, or accept new data per field – prior assessments and narrative stay intact.
Proportional effort Trivial corrections, like a patient-initials fix, no longer force a full case re-assessment cycle.
Complete audit trail Follow-ups and amendments are classified and timestamped automatically, even if the source omits the flag.

Why This Matters Beyond Convenience

  • Faster turnaround on regulatory reporting timelines, since specialists spend less time reconstructing context and more time on substantive review.
  • Reduced risk of lost clinical judgment, since prior causality assessments and coding decisions no longer disappear when a new version arrives.
  • More consistent audit trails, since every update – however it entered the system – gets properly classified and traced.
  • Scalable case management, since teams handling high-volume products or serious cases with many follow-ups aren’t penalized with linearly increasing manual effort per version.

Blog

How Flex Databases’ Review and Merge Tool Transforms Pharmacovigilance Case Processing

Every pharmacovigilance case tells an evolving story. A case rarely arrives once and stays static – new information keeps surfacing after the initial intake: a patient is hospitalized, a birth date gets corrected, a new reaction is reported, a concomitant medication comes to light. For safety teams processing cases from clinical trials, marketed-drug consumer reports, […]

July 23, 2026
Why FluoGuide Chose Flex Databases as eTMF and CTMS Provider

FluoGuide lights up cancer to maximize surgical outcomes in oncology and its lead product, FG001, is designed to improve surgical precision. FluoGuide is listed on Nasdaq First North Sweden under the ticker “FLUO”. (Q) What clinical trial management challenges led you to seek a new system? Our main challenges were inefficiencies caused by disconnected systems, […]

July 21, 2026
Protocol Deviations Start Earlier Than You Think

Most sponsors associate protocol deviations with events that occur later in a clinical trial, like missed visits or incomplete documentation. In reality, one of the earliest and most consequential protocol deviations is happening during patient randomization. Randomization is often perceived as a simple operational step:patient enrolled, button clicked, treatment assigned. But under the pressure of […]

July 17, 2026
Why Long-Established eClinical Platforms Are Slowing Down Modern Clinical Trials 

What Sponsors Should Really Look For When Choosing an eClinical Platform?  Today, every established vendor offers all kinds of system modules, document management capabilities, and a long list of compliance certifications.  On paper, they appear remarkably similar, making it increasingly difficult for sponsors and CROs to distinguish between solutions based on feature lists alone.  In reality, they couldn’t be more different.  Most enterprise eClinical platforms can […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.